ResMed Quarterly Cash Flow Statement
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ResMed free cash flow
In the quarter ended Jun 30, 2026, ResMed generated $454.6 million of operating cash flow and spent $51.1 million on capital expenditures. That left free cash flow of $403.5 million, a free-cash-flow margin of 27.6% of revenue. Free cash flow was down 20.6% from the prior year's $508.2 million.
ResMed returned $287.1 million to shareholders: $87.1 million in dividends and $200.0 million in share repurchases, equal to 71% of free cash flow. Free cash flow covered dividend payments 4.6 times.
Summary generated from market data by MetaCap's automated system. Methodology
ResMed cash flow statement (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 383.43M | 398.73M | 392.59M | 348.54M | 379.70M | 365.04M | 344.62M | 311.36M | 292.24M | 300.49M | 208.80M | 219.42M |
| Net Income growth (YoY) | +0.98% | +9.23% | +13.92% | +11.94% | +29.93% | +21.48% | +65.05% | +41.90% | +27.25% | +29.24% | -7.16% | +4.25% |
| Depreciation & Amortization | 44.78M | 58.98M | 49.88M | 47.70M | 63.63M | 43.67M | 46.44M | 44.73M | 43.68M | 43.47M | 44.78M | 44.93M |
| Stock-Based Compensation | 27.46M | 26.79M | 28.94M | 21.16M | 24.75M | 24.12M | 22.63M | 20.16M | 21.39M | 20.44M | 19.84M | 18.51M |
| Change in Working Capital | -8.37M | 51.16M | -142.29M | 25.25M | 58.76M | 132.28M | -114.90M | -59.40M | 57.13M | 40.81M | -43.57M | -9.59M |
| Operating Cash Flow | 454.63M | 554.13M | 339.75M | 457.32M | 538.77M | 578.66M | 308.62M | 325.54M | 440.11M | 402.03M | 272.83M | 286.28M |
| Capital Expenditures | -51.13M | -33.65M | -28.54M | -42.97M | -30.59M | -20.80M | -20.64M | -17.84M | -24.88M | -21.19M | -23.35M | -30.04M |
| Investing Cash Flow | -383.65M | -58.03M | -50.94M | -52.58M | -133.71M | -31.79M | -36.69M | 2.15M | -46.51M | -33.15M | -41.14M | -148.98M |
| Dividends Paid | -87.09M | -87.24M | -87.58M | -87.75M | -77.59M | -77.70M | -77.69M | -77.89M | -70.55M | -70.49M | -70.68M | -70.60M |
| Share Repurchases | -200.00M | -175.01M | -175.01M | -150.01M | -100.01M | -75.03M | -74.99M | -50.01M | -50.00M | -50.00M | -50.01M | 0 |
| Debt Issued | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105.00M |
| Debt Repaid | -5.00M | 0 | -5.00M | 0 | -5.00M | 0 | -5.00M | -30.00M | -300.00M | -220.00M | -130.00M | -185.00M |
| Financing Cash Flow | -263.16M | -255.24M | -258.35M | -230.27M | -163.89M | -144.07M | -147.54M | -150.76M | -393.28M | -335.91M | -238.96M | -151.13M |
| Net Change in Cash | -191.28M | 243.44M | 33.22M | 174.40M | 276.74M | 410.77M | 95.58M | 188.00M | 451.00K | 27.66M | 1.15M | -18.79M |
| Free Cash Flow | 403.50M | 520.48M | 311.21M | 414.36M | 508.18M | 557.87M | 287.98M | 307.70M | 415.23M | 380.84M | 249.48M | 256.25M |
This table shows 12 quarterly periods of ResMed's cash flow statement, from Q4 2026 back to Q1 2024, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RMD's reporting calendar. What is a cash flow statement?